NCT05055297

SELUTION4BTK Trial

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2022-05-19Est. Completion: 2027-06-01

Enrollment target: 376 participants

Locations

Chandler Regional Medical Center, Chandler, Arizona, United States
St. Bernards Medical Center, Jonesboro, Arkansas, United States
Arkansas Heart Hospital, Little Rock, Arkansas, United States
St. Helena Hospital, St. Helena, California, United States
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States
ClinRé, Thornton, Colorado, United States
Vascular Care Group, Darien, Connecticut, United States
Yale University, New Haven, Connecticut, United States
The Cardiac and Vascular Institute Research Foundation, Gainesville, Florida, United States
Palm Vascular Centers, Miami, Florida, United States
Guardian Research Organization, LLC, Winter Park, Florida, United States
Cardiovascular Consultants of South Georgia, Thomasville, Georgia, United States
Rush University Medical Center, Chicago, Illinois, United States
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
Cardiovascular Institute of the South, Gray, Louisiana, United States

Critical Limb Ischemia

Pre-market clinical evaluation of the MOTIV Sirolimus-Eluting Bioresorbable Scaffold for the planned treatment of infrap…

St. Helena, United StatesEst. completion Apr 30, 2026

Peripheral Arterial Disease

To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for …

Santiago, ChileCompleted Sep 2018

Critical Ischemia Limb

Peripheral arteriopathy disease (PAD) affects 1 million people in France. In its most advanced stage: chronic permanent …

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.